Skip to main content
. 2019 May 23;18:2. doi: 10.4103/jcar.JCar_2_19

Figure 3.

Figure 3

The general architecture of a chimeric antigen receptor consists of a single-chain variable fragment derived against a predetermined tumor-associated antigen followed by a CD3ζ domain required for provision of signal 1 and T-cell activation upon antigen recognitionBayraktar